The little-known history of how groups of slaves, native American Indians and Cajun settlers helped change the outcome of the American Revolutionary War.
The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.
- Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
- Marc Kaufman reporter on the national desk of "The Washington Post"
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sandra Kweder deputy director of the FDA's Office of New Drugs
Most Recent Shows
California passes a new law requiring all children enrolled in school to be vaccinated. It's the largest state in the nation to do so. The push to require vaccinations and the tension between public health and personal beliefs.
A look at the growing fossil fuel divestment movement.
The Supreme Court rules that independent commissions can draw state voting lines. What will the decision mean for efforts to curtail gerrymandering across the country?